Other News

Reprieve Cardiovascular Completes Enrollment in Randomized Pilot Trial Evaluating First-of-its-Kind Personalized Fluid Management System for Acute Decompensated Heart Failure

MILFORD, Mass.–(BUSINESS WIRE)–Reprieve Cardiovascular, Inc., a development-stage company pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, today announced the completion of enrollment in the “Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (“FASTR”)” trial. “For decades, managing fluid removal in patients with […]

Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical

SAN MATEO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today filed a patent infringement lawsuit against Q’Apel Medical alleging infringement of five U.S. patents held by Route 92 Medical, which protect the Tenzing® delivery catheter. The complaint was filed October 7, 2024, in the United States District Court for the District of Delaware.

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2025, which ended August […]

Arineta Launches First SpotLight™ Duo in Northeast at Lehigh Valley Health Network

Caesarea, Israel – Oct. 3, 2024 – Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, announces the installation of its SpotLight™ Duo cardiac CT scanner at Lehigh Valley Health Network’s (LVHN) cardiac diagnostic center in Gilbertsville, Pennsylvania. This installation through Lehigh Valley Imaging makes the SpotLight Duo […]

Imperial College London Study Finds Eko Health AI Predicts Patients With High Risk of Major Adverse Cardiac Events

Patients identified with reduced ejection fraction using Eko Health AI were twice as likely to experience heart attacks, heart failure, hospitalization, and all-cause mortality over two years. SAN FRANCISCO, Oct. 2, 2024 /PRNewswire/ — Eko Health, a pioneer in applying artificial…

Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pounce™ XL Thrombectomy System. “Securing FDA clearance for the Pounce XL Thrombectomy System is a major step […]

Heart Failure Society of America and Elsevier Announce New addition to the Journal of Cardiac Failure Family: JCF-Intersections

WASHINGTON, Oct. 1, 2024 /PRNewswire/ — The Heart Failure Society of America (HFSA) announced today during their Annual Scientific Meeting the launch of a new journal, JCF-Intersections (JCF-I), in partnership with Elsevier. This new journal will join the JCF Family of Journals, led by…

Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS® AcuFORM™ Left Atrial Appendage Occlusion Device

Study will assess the Company’s Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. NASHUA, N.H., Oct. 1, 2024 /PRNewswire/ — Conformal Medical, Inc. today announced the initiation of the GLACE Study. This…